Wang Qingwen Q - OmicsDI

Show results for

Unknown (4)
Proteomics (1)
Metabolomics (1)

Organisms

Homo sapiens (1)

Repository

iProX (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2021 (1)
2025 (1)

Metabolite Name

PE(20:2(11Z,14Z)/20:4(6E,8Z,11Z,14Z)+=O(5)) (1)
PA(21:0/LTE4) (1)
CL(15:0/18:2(9Z,11Z)/18:2(9Z,11Z)/25:0) (1)
1alpha-hydroxy-23-[3-(1-hydroxy-1-methylethyl)phenyl]-22,22,23,23-tetradehydro-24,25,26,27-tetranorvitamin D3 / 1alpha-hydroxy-23-[3-(1-hydroxy-1-methylethyl)phenyl]-22,22,23,23-tetradehydro-24,25,26, 27-tetranorcholecalciferol (1)
PE(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,13E)-OH(15S)) (1)
PA(21:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (1)
PS(19:1(9Z)/20:3(8Z,11Z,14Z)) (1)
PE(14:0/6 keto-PGF1alpha) (1)
PS(15:0/6 keto-PGF1alpha) (1)
PS(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) (1)
PG(18:0/18:2(10E,12Z)+=O(9)) (1)
CL(18:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (1)
CL(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (1)
PE(16:1(9Z)/5-iso PGF2VI) (1)
PI(16:2(9Z,12Z)/TXB2) (1)
Concanamycin a (1)
PS(16:0/PGF1alpha) (1)
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/21:0/0:0) (1)
1alpha,25-dihydroxy-24a,24b-didihomo-22-thia-20-epivitamin D3 / 1alpha,25-dihydroxy-24a,24b-didihomo-22-thia-20-epicholecalciferol (1)
12,14-Heptacosadiynoic acid (1)
PC(18:1(11Z)/18:3(10,12,15)-OH(9)) (1)
PG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (1)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/PGF1alpha) (1)
PG(12:0/18:2(9Z,12Z)) (1)
PA(22:2(13Z,16Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (1)
5beta-Cholestane-2beta,3alpha,7alpha,12alpha,26-pentol (1)
8-hydroxy-11E-octadecen-9-ynoic acid (1)
PA(13:0/18:1(12Z)-2OH(9,10)) (1)
PGP(16:0/6 keto-PGF1alpha) (1)
PG(a-25:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) (1)

Release Date

2024 (1)
2023 (1)
2022 (1)
2020 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19.

Not available

S-EPMC9540507 | biostudies-literature

Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study.

Not available

S-EPMC9896853 | biostudies-literature

Ten Mouse Organs Proteome and Metabolome Atlas from Adult to Aging

The complexity of the aging process, encompassing numerous organs and systems, poses a significant challenge in identifying and targeting key factors that drive age-related decline. The multi-organ synchronous molecular intricacies underlying natural aging remain elusive. Here we presented a data...

2025-08-29 | MTBLS10642 | MetaboLights

Clinical efficacy of Fufang Yinhua Jiedu (FFYH) granules in mild COVID-19 and its anti-SARS-CoV-2 mechanism by blocking autophagy through inhibiting the AKT/mTOR signaling pathway.

Not available

S-EPMC11439717 | biostudies-literature

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version).

Not available

S-EPMC7472403 | biostudies-literature

Arginine methylation of METTL14 promotes RNA N6-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells

m6A is the most abundant modification of mRNA in mammals and plays an important role in human development and disease. METTL14 is a key component of m6A methyltransferase complex. The project showed that its post-translational arginine methylation can regulate the generation of m6A and the endoderm ...

ORGANISM(S): Homo Sapiens

2021-05-17 | PXD018458 |

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

6 Results

Show results for

Organisms

Repository

Technology Type

Instrument Platform

Publication Date

Metabolite Name

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets